1. Home
  2. MAMA vs PGEN Comparison

MAMA vs PGEN Comparison

Compare MAMA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

N/A

Current Price

$16.11

Market Cap

622.0M

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$3.42

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAMA
PGEN
Founded
2010
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
622.0M
1.6B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
MAMA
PGEN
Price
$16.11
$3.42
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$16.80
$7.67
AVG Volume (30 Days)
509.8K
4.7M
Earning Date
03-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$95,420,129.00
$230,981,000.00
Revenue This Year
$41.59
$342.78
Revenue Next Year
$33.43
$478.46
P/E Ratio
$208.13
N/A
Revenue Growth
95.54
N/A
52 Week Low
$5.63
$1.11
52 Week High
$17.85
$5.47

Technical Indicators

Market Signals
Indicator
MAMA
PGEN
Relative Strength Index (RSI) 53.16 35.65
Support Level $14.54 $2.99
Resistance Level $16.68 $5.10
Average True Range (ATR) 0.80 0.28
MACD -0.10 -0.10
Stochastic Oscillator 48.94 9.70

Price Performance

Historical Comparison
MAMA
PGEN

About MAMA Mama's Creations Inc.

Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: